Data Bytes: How can biomarkers de-risk drug development?

Data Bytes: How can biomarkers de-risk drug development?

Biomarkers can play a crucial role in de-risking drug development by providing measurable indicators of biological processes associated with disease onset, progression, and treatment response. In this episode of Data Bytes, we spoke with Dr Alexander Koch, Team Lead...
BioLizard and AbnomX announce partnership

BioLizard and AbnomX announce partnership

BioLizard’s custom advanced analytics services complement AbnomX’s innovative, user-friendly platform for deciphering immune repertoire data. GHENT, Belgium April 2nd, 2024 – AbnomX and BioLizard announced a strategic partnership today. AbnomX are pioneers...